Hap Trading, LLC Caladrius Biosciences, Inc. Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.41 - $0.74 $14,883 - $26,862	-36,300 Reduced 42.11%	49,900 $0
Q1 2022 May 12, 2022	BUY	$0.63 - $1.03 $43,281 - $70,761	68,700 Added 392.57%	86,200 $1,000
Q4 2021 Feb 14, 2022	BUY	$0.83 - $1.22 $14,525 - $21,350	17,500 New	17,500 $1,000
Q3 2021 Nov 10, 2021	SELL	$1.15 - $1.57 $12,304 - $16,799	-10,700 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$1.4 - $1.9 $9,380 - $12,730	-6,700 Reduced 38.51%	10,700 $0
Q1 2021 May 14, 2021	BUY	$1.44 - $2.89 $2,880 - $5,780	2,000 Added 12.99%	17,400 $4,000
Q4 2020 Feb 16, 2021	BUY	$1.39 - $1.87 $3,474 - $4,675	2,500 Added 19.38%	15,400 $0
Q3 2020 Nov 13, 2020	BUY	$1.6 - $3.0 $20,640 - $38,700	12,900 New	12,900 $2,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.